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Abstract
The orexinergic neurons of the lateral hypothalamus (Orx) are essential for regulating sleep-wake dynamics, and their loss
causes narcolepsy, a disorder characterized by severe instability of sleep and wake states. However, the mechanisms
through which Orx stabilize sleep and wake are not well understood. In this work, an explanation of the stabilizing effects of
Orx is presented using a quantitative model of important physiological connections between Orx and the sleep-wake
switch. In addition to Orx and the sleep-wake switch, which is composed of mutually inhibitory wake-active monoaminergic
neurons in brainstem and hypothalamus (MA) and the sleep-active ventrolateral preoptic neurons of the hypothalamus
(VLPO), the model also includes the circadian and homeostatic sleep drives. It is shown that Orx stabilizes prolonged waking
episodes via its excitatory input to MA and by relaying a circadian input to MA, thus sustaining MA firing activity during the
circadian day. During sleep, both Orx and MA are inhibited by the VLPO, and the subsequent reduction in Orx input to the
MA indirectly stabilizes sustained sleep episodes. Simulating a loss of Orx, the model produces dynamics resembling
narcolepsy, including frequent transitions between states, reduced waking arousal levels, and a normal daily amount of total
sleep. The model predicts a change in sleep timing with differences in orexin levels, with higher orexin levels delaying the
normal sleep episode, suggesting that individual differences in Orx signaling may contribute to chronotype. Dynamics
resembling sleep inertia also emerge from the model as a gradual sleep-to-wake transition on a timescale that varies with
that of Orx dynamics. The quantitative, physiologically based model developed in this work thus provides a new
explanation of how Orx stabilizes prolonged episodes of sleep and wake, and makes a range of experimentally testable
predictions, including a role for Orx in chronotype and sleep inertia.
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Introduction
Since the discovery of the orexin A and orexin B neurotrans-
mitters (also termed hypocretin 1 and 2) by Sakurai et al. [1] and
de Lecea et al. [2] in 1998, the orexinergic neurons of the lateral
hypothalamic area (Orx) have been implicated in a wide range of
neurological processes, including a key role in the regulation of
sleep and wake [3,4]. The orexins have also been shown to have a
role in feeding, emotion, reward function, and motivation [1,5–8].
The neurodegenerative disorder narcolepsy [9] is characterized by
a loss of approximately 90% of Orx [10], and is a condition that
affects approximately 0.05% of the population [11]. It is thought
that some process–perhaps an autoimmune attack [12]–selectively
destroys these orexinergic cells [13]. Narcolepsy is characterized
by awakenings during sleep, unintentional naps during wake,
drowsiness, and difficulty in waking from sleep [14]. The condition
is often accompanied by cataplexy, the sudden loss of muscle tone
triggered by strong emotions [15], although over one quarter of all
narcoleptics do not have cataplexy [11], perhaps due to less severe
loss of Orx [16,17].
Although the link between the loss of Orx and narcolepsy has
been established and the key neurological pathways of Orx are
known, the mechanisms through which loss of Orx causes
narcoleptic symptoms remain unclear [18]. For example, it is
commonly thought that Orx excites the wake-promoting mono-
aminergic neurons (MA) during wake and thereby acts to stabilize
the sleep-wake switch [19,20], but it is not clear how Orx also
stabilizes sleep, the destabilization of which is a hallmark of
narcolepsy [15]. Homeostatic control of sleep in narcoleptics is
thought to be normal, since they exhibit normal recovery from
sleep deprivation and have a normal total daily sleep duration [9].
The underlying circadian dynamics in both orexin knockout mice
and narcoleptic humans also appears to be normal [9,21]. Thus,
despite apparently normal homeostatic and circadian processes, a
reduction in Orx somehow produces ‘behavioral state instability’,
with low thresholds to transition between sleep and wake [9,22].
In this work, we present a detailed, physiologically justified
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e91982explanation of this phenomenon and explain how the loss of Orx
gives rise to these characteristically low thresholds for behavioral
state transitions in narcolepsy.
Phenomenological models of sleep-wake dynamics that have
built upon Borbe ´ly’s two-process model [23] have been successful
in predicting a range of sleep-wake behaviors [24], including
subjective fatigue during sleep deprivation, internal desynchroni-
zation, fragmented sleep during continuous bedrest, and the sleep
durations of shift workers [25,26]. However, incorporating Orx
into such models is problematic because they lack a physiological
framework. In contrast, physiologically based models of sleep
represent the neuronal populations and their interactions explic-
itly, allowing new physiological information to be incorporated
straightforwardly. Following advances in the understanding of key
sleep-regulatory nuclei in the brainstem and hypothalamus
[27,28], a range of physiologically based sleep models have been
developed [29–34]. In this work we build on the Phillips-Robinson
model of the sleep-wake switch [35], which is based on the
mutually-inhibitory sleep-active ventrolateral preoptic nucleus
(VLPO) and the wake-active monoaminergic hypothalamic and
brainstem neuronal populations (MA). The model produces flip-
flop dynamics between sleep and wake, as driven by homeostatic
and circadian processes. Although sleep/wake dynamics are
known to be regulated by a variety of processes [36], the
Phillips-Robinson model captures the core dynamics of the sleep-
wake switch, which turns out to be a powerful approximation.
Despite being fitted using a relatively small set of behavioral and
physiological data, the model has predicted the results of many
experiments, while providing insights into the physiological
dynamics that underly its predictions, including sleep deprivation
[37,38], sleep fragmentation [39], caffeine intake [40], mamma-
lian sleep [41], shift work [42], and internal desynchrony [43], and
has successfully predicted sleep latencies [37], arousal thresholds
[39], and subjective fatigue levels [38].
The paper is structured as follows. First we explain the
mathematical formulation of the new model in terms of the
relevant physiology. The dynamics of the model are then
characterized in terms of net drives to the sleep-active VLPO
and the wake-active MA: Dv and Dm, respectively. Different
combinations of these drives are shown to control whether: (i) the
system is awake, (ii) the system is asleep, or (iii) sleep and wake are
simultaneously stable, with characteristic thresholds for transitions
between the states. These results allow us to explain how Orx’s
known mechanisms, including exciting the MA, relaying a
circadian signal to the MA, and being inhibited by the VLPO,
all act to stabilize extended bouts of sleep and wake. By including
noise in the model and simulating the loss of Orx, we show that the
model generates increasingly fragmented sleep-wake time series, as
is characteristic of narcolepsy. Finally we show that dynamics
resembling sleep inertia result from including Orx in the model,
and we link the timescale of this gradual sleep-to-wake transition to
that of Orx dynamics.
Models
In this section, we develop a new sleep model that includes Orx,
giving a non-mathematical overview of the physiology and model
structure first, and then providing further mathematical details.
The new model is an extension of an existing model by Phillips
and Robinson [35], which has been characterized in detail
previously [37,39]. The model includes the interactions between
three key neuronal populations: VLPO, MA, and Orx, as well as
the circadian and homeostatic drives. Although a wide range of
processes are thought to regulate sleep [36], VLPO, MA, and Orx
are known to play central roles [19], and here we show that many
salient features of healthy and pathological sleep can be captured
by considering just this reduced system. Note that because we do
not distinguish between REM sleep and different stages of NREM
sleep (since the physiological basis for these dynamics are yet to be
pinned down [44]), we do not attempt to model transitions
between NREM and REM sleep stages, nor any effect of Orx on
the frequency and timing of these transitions [19,21]. The link
between Orx loss and cataplexy [15] is also not investigated here;
we group the monoaminergic nuclei as a uniform population,
whereas cataplexy involves a discoordination of firing activity
across the monoaminergic nuclei [45]. Such dynamics could be
explored in future work (cf. [44]), but here we focus solely on the
dynamics of sleep and wake.
Physiology and Model Overview
The flip-flop dynamics of sleep and wake are proposed to result
from the mutual inhibition of wake-active MA and sleep-active
VLPO [27,46]. The MA group includes nuclei that use
monoaminergic neurotransmitters: the histaminergic tuberomam-
millary nucleus (TMN), norepinephrinergic locus coeruleus (LC),
serotoninergic dorsal raphe ´ nucleus (DR), and dopaminergic
ventral tegmental area (VTA) [47–49]. Orx excites the MA during
wake [8,19,50]. Monoaminergic neurotransmitters inhibit the
VLPO, and the VLPO inhibits the MA via GABAergic projections
[4,51,52]. Due to the mutual inhibition between the MA and
VLPO populations, only a single population is active at any one
time, and the dynamics resemble that of an electronic flip-flop
circuit [27]. This provides the basis for consolidated bouts of either
sleep (active MA, suppressed VLPO) or wake (active VLPO,
suppressed MA), with the active population determined by the net
inputs, or drives, to each population. Although populations other
than the VLPO have been implicated as having a role in inducing
and/or maintaining sleep, including the median preoptic nuclei
(MnPO) [19], melanin-concentrating hormone cells in the
hypothalamus [53], neurons in the striatum and globus pallidus
[54], the rostral medullary brainstem [55], and thalamus [56],
here we focus on the important role of the VLPO [57] and note
that this component of the model could in principle represent one
or more sleep-promoting centers that act in concert.
The dynamics of sleep and wake are thought to be controlled
primarily by the circadian, C, and homeostatic, H, drives [23,25].
The 24 h periodic circadian signal, which originates in the
suprachiasmatic nucleus of the hypothalamus (SCN), is entrained
by the light/dark cycle [4]. The VLPO receives an inhibitory
circadian projection, while Orx receives an excitatory circadian
projection, primarily via the dorsomedial nucleus of the hypothal-
amus (DMH) [4,58,59]. The homeostatic sleep drive, H, increases
during wake and decreases during sleep, and may correspond to
some sleep-regulatory substance [60,61], such as adenosine
[62,63] or cytokines [36,64]. The homeostatic sleep drive
disinhibits the VLPO [4,52].
A schematic depiction of the model, which includes the
neuronal interactions and drives described above, is shown in
Fig. 1A. For analytical purposes, the model can be analyzed in a
reduced representation that focuses on the MA–VLPO sleep-wake
switch, as shown in Fig. 1B. In this picture, net external drives to
the VLPO and MA are grouped as Dv and Dm, respectively, and
control the evolution of arousal state over time: Dv includes
inhibition from C and disinhibition from H, while Dm includes an
excitatory input from Orx, which itself receives an excitatory input
from C. This reduced representation is used in this work help
explain how Orx acts to stabilize sleep and wake by modulating
Dm. The remainder of this section contains details of how the
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mathematically.
Neuronal Interactions
Our model captures the average properties of populations of
neurons and their interactions [65], and is based on previously
successful approaches to modeling the corticothalamic system [65–
67]. Each population, j~v,m,x, where v stands for VLPO, m for
MA, and x for Orx, is represented by its mean cell-body potential
relative to resting, Vj(t). The mean firing rate of each population,
Qj(t), is approximated by a sigmoidal function of Vj(t) [68]:
Qj:S(Vj)~
Qmax
1zexp½{(Vj{h)=s
0 
, ð1Þ
where Qmax is the maximum possible firing rate, h is the mean firing
threshold relative to resting, and s
0
p=
ﬃﬃﬃ
3
p
is its standard deviation
[66]. Due to the small volume of the relevant nuclei, we assume
spatial homogeneity of each population and neglect propagation
delays between neurons. This assumption is reasonable because
interactions within the relevant neuronal populations occur on
timescales of milliseconds, whereas we are interested in capturing
arousal-state dynamics that occur on timescales of seconds or
longer. We assume that changes in postsynaptic potentials are
proportional to the firing rates, Qj, of the presynaptic populations,
and use the constants, nij, to represent the strength of the synaptic
connection from population j (~v,m,x) to population i (~v,m,x).
Time constants, tj, control the rate at which the dynamics of Vj
evolve via the decay rate of neuromodulator effects.
The equations governing the VLPO (v) and MA (m) populations
are as follows:
tv
dVv
dt
~{VvznvmQmzDvzjv(t), ð2Þ
tm
dVm
dt
~{VmznmvQvzDmzjm(t), ð3Þ
where the negative coefficients, nvmv0 and nmvv0, capture the
mutual inhibition of the two populations [27,46]. Net drives are
grouped as Dv and Dm, while jv(t) and jm(t) are independent,
Gaussian-distributed, zero-mean white noise processes with
standard deviations sv and sm, respectively. These noise variables
represent the inherent noise in biological processes and fluctuating
external inputs to these populations. In the absence of physiolog-
ical data to estimate the relative noisiness of drives to the VLPO
and MA, we set them equal here for simplicity (i.e., s~sv~sm)s o
that jv~N(0,s) and jm~N(0,s). Equations (2) and (3) thus
capture the flip-flop dynamics between the VLPO and MA [27].
Orx is modeled as a neuronal population in the same way as for
the MA and VLPO, with dynamics governed by.
tx
dVx
dt
~{VxznxvQvzDx, ð4Þ
where nxvv0 captures the inhibition of Orx by the VLPO [8,69],
and drives to Orx are grouped as Dx. Due to inhibition from the
VLPO, Orx is suppressed during sleep, but is active during wake
when the VLPO is inactive. Orx may receive inhibitory inputs
from serotonin and norepinephrine [50], while noradrenergic
input has been shown to be excitatory, but inhibitory following
sleep deprivation [70]; other studies have reported no reciprocal
connections from monoamine-containing groups that are inner-
vated by Orx [71]. Given this uncertainty in the net connection
between MA and Orx, we assume it to be small relative to the
other terms modeled in Eq. (4) and neglect it by setting nxm~0
here. We note that a large positive nxmw0 could produce an
instability in the model with mutually-excitatory Orx and MA
reinforcing the behavior of each other during wake (that would
require the modeling of additional systems to stabilize), while small
negative connections, nmxv0, could be accommodated with
relatively minimal affect on the qualitative dynamics reported
here [e.g., compensating by increasing both jnxvj and Ax, cf. Eq.
(9)]. A noisy input to Orx is not included for simplicity, because
Orx excites the MA in the model, which itself receives a direct
noisy input, jm(t). If modeled, input noise to Orx, jx(t), added to
Eq. (4), would be relayed to the MA during wake when Orx is
active, but suppressed during sleep when Orx is inactive,
Figure 1. Schematic of the model. The model includes interactions between the sleep-active ventrolateral preoptic area of the hypothalamus
(VLPO), the wake-active monoaminergic brainstem nuclei (MA), and the orexinergic neurons of the lateral hypothalamic area (Orx), as well as the
circadian (C) and homeostatic (H) drives. Arrows indicate interactions between the populations, as well as the pathways of the circadian and
homeostatic drives, and represent either excitatory (z) or inhibitory ({) interactions. A All modeled interactions are shown, including the mutual
inhibition between VLPO and MA [27], inhibition of Orx by VLPO [8], and excitatory input from Orx to MA [72]. The circadian drive, C, which originates
in the suprachiasmatic nucleus (SCN), is afferent to both VLPO (inhibition) and Orx (excitation) [4], while the homeostatic sleep drive, H, which
increases during wake and decreases during sleep, disinhibits VLPO [63]. Example two day time traces for normal sleep-wake behavior are annotated
below the C and H drives. B The model can be mathematically reduced to the core dynamics of mutual inhibition between the sleep-active VLPO
and wake-active MA groups. In this representation, net drives, Dv and Dm, to VLPO and MA, respectively, control the arousal state dynamics. This
reduced representation is used throughout this work to visualize and understand the model dynamics.
doi:10.1371/journal.pone.0091982.g001
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The circadian drive for wake is taken to be entrained to the
daily light/dark cycle and is approximated by a sinusoidal function
of time,
C(t)~sinvt, ð5Þ
where v~(2p=24) {1. An oscillation amplitude of unity is used
without loss of generality because the actual amplitude is absorbed
into the weights, nvc and nxc, that control the circadian inputs to
VLPO and Orx, respectively, while any constant offsets in C are
incorporated in the constants Av and Ax in Eqs (7) and (9),
respectively. This sinusoidal form of C is used here for simplicity,
but we note that dynamic circadian oscillator models can also be
implemented straightforwardly [42,43].
The dynamics of the homeostatic sleep drive, H, depend on the
arousal state, as described above. Our model of H is based on a
sleep-promoting factor that increases during wake when the MA is
active (Qm is high) and decreases during sleep when the MA is
suppressed (Qm&0). These dynamics are described by
x
dH
dt
~{Hzmh
Q2
m
ghzQ2
m
, ð6Þ
where x sets the timescale on which H changes, and the constants
mh and gh control the dependence of H production on Qm.I n
some previous work, a linear H production term was used [35],
which is appropriate for modeling basic sleep-wake dynamics
when Qm does not vary significantly during wake. In this work,
however, waking arousal states with very different Qm are
simulated, and thus the saturating form of the final term in Eq.
(6) (introduced previously [38]) is required to avoid unreasonably
large disparities in H production between waking states with
different Qm.
Net drives to each neuronal population are defined as follows:
Dv~nvcCznvhHzAv, ð7Þ
Dm~nmxQxzAm, ð8Þ
Dx~nxcCzAx, ð9Þ
where nvcv0 because the VLPO receives an inhibitory projection
from the DMH, which itself receives an excitatory circadian
projection [4,59]; nvhw0 because the homeostatic process H
disinhibits the VLPO [4,52,63]; nmxw0 because Orx excites the
MA [72] (including the DR [73], LC [74], and TMN [75]); and
nxcw0 because Orx receives a strong excitatory circadian
projection from the DMH [4,58]. Inhibition of Orx by homeo-
static sleep-regulatory substances [76] is assumed to be small and is
neglected here by setting nxh~0. Constants, Ai, represent time-
averaged inputs to each population from external sources not
explicitly modeled here, and could include any constant offsets of
the circadian drive for Av and Ax, or any time-averaged
cholinergic inputs to the MA for Am, for example. Altogether,
Dv includes inhibition from C and disinhibition from H, Dm varies
with Orx activity, and Dx is circadian. The excitation of MA by
Orx is included as the nmxQx term in Dm [Eq. (8)] rather than
appearing directly in Eq. (3), which is mathematically equivalent
but allows us to focus on the sleep-wake switch by interpreting Orx
as a component of Dm. This excitatory input to the MA is the only
effect of Orx on the rest of the model, and hence Orx loss can be
simulated by reducing the single parameter nmx. Finally note that
because the drive to Orx, Dx, affects the sleep-wake switch only
through Dm, we can focus on a reduced form of the model in
which the dynamics are summarized by the values of Dv and Dm,
as in Fig. 1B. This approximation is valid if Dv and Dm are slowly-
varying compared to the dynamics of Vv and Vm, which holds
here because C and H vary on the timescale of a day, and
tx&tv,tm.
Parameter Constraints and Computation
Compared to the original Phillips-Robinson model, the current
model includes new parameters, as well as adjustments to some
existing parameters, as listed in Table 1. Most existing parameters
are unchanged, with new and altered parameters shown in
boldface in Table 1. We maintain as much compatibility with
previous work as possible to ensure that previous model
predictions are retained and that changes to the model’s structure
represent improvements rather than simply providing more
flexibility to fit the phenomena presented here. For example, the
new model reproduces both the normal flip-flop sleep-wake
dynamics of the Phillips-Robinson model, and the same behavior
during total sleep deprivation as reported previously [38] (see File
S1).
Parameters are constrained separately in different dynamical
regimes of the model. With Orx absent from the model, the
qualitative dynamics should reflect a severe narcoleptic or Orx-
knockout phenotype, which we use to constrain the constant
inputs, Am and Av, the circadian parameters, nvc and nxc, and the
noise variance, s. The homeostatic production parameters, mh and
gh, are set to maintain approximately eight hour daily sleep
durations across a range of nmx; tx is set to match the empirical
timescale of sleep inertia (explained in detail later); and the Orx
parameters, Ax, nmx, and nxv, are set to maintain normal sleep-
wake behavior. Further details of how the parameters are
constrained, including justifications for all parameter values, are
in File S1. Note that the aim of this study is not to perform
rigorous parameter constraints by fitting to clinical datasets (which
could be performed in future), but rather to show that
physiologically reasonable values of parameters exist that can
plausibly account for clinical observations of narcolepsy.
The current model differs from the original Phillips-Robinson
model [35] in two key ways. Most obviously, the new model
includes Orx [Eq. (4)], which contributes a time-varying drive to
the MA that was previously constant (the parameter A in the
original model). The other major change is the reduced magnitude
of circadian input to the VLPO, nvc. In the Phillips-Robinson
model, the circadian drive affected the sleep-wake switch only as
an input to VLPO, with nvc~{2:9 mV [35]. However, following
VLPO lesions, strong circadian rhythmicity in sleep-wake
behavior persists [57], and Orx has been shown to play an
important role in the circadian control of sleep [77]. These
experimental results suggest that the dominant circadian input to
the sleep-wake switch may be via Orx to MA. The parameters
used in this model reflect this, with nxc~z1:0 mV s and
Model of Orexin and Sleep-Wake Stability
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producing noisier waking periods, but otherwise having a minimal
effect on the model dynamics.have been shown to generate sleep phenotypes of other
mammalian species [78]).
Combining the definitions of the neuronal interactions and
drives above, the output of the full model is the solution of the
following four coupled differential equations:
tv
dVv
dt
~{VvznvmS(Vm)znvcCznvhHzAvzjv(t), ð10Þ
tm
dVm
dt
~{VmznmvS(Vv)znmxS(Vx)zAmzjm(t), ð11Þ
tx
dVx
dt
~{VxznxvS(Vv)znxcCzAx, ð12Þ
x
dH
dt
~{Hzmh
½S(Vm) 
2
ghz½S(Vm) 
2 , ð13Þ
where C is defined in Eq. (5). When noise is included in the model,
these stochastic differential equations are solved numerically using
the Euler-Marayama method [79] with a time step Dt~1 s (time
steps Dt 5 s produced sufficiently converged dynamics). The
model can be simulated without noise by removing the terms jv(t)
and jm(t) from Eqs (10) and (11), whence the model equations
reduce to four coupled ordinary differential equations that are
solved numerically using the variable-order solver for stiff
problems, ode23s, in Matlab 2011b (Matlab is a product of
The MathWorks, Natick, MA). Throughout this work, periods in
which QmwQv are labeled ‘wake’ and periods in which QmƒQv
are labeled ‘sleep’; transient noisy fluctuations in state lasting less
than 60 s are ignored (the main results are not sensitive to this
state-labeling heuristic, see File S1).
Results and Discussion
In this section a detailed analysis of the model is used to
characterize Orx’s role in sleep-wake dynamics. First we
investigate the model’s dynamical properties in terms of the net
drives to the sleep-active VLPO and wake-active MA: Dv and Dm,
respectively. The results are used to explain how the loss of Orx in
the model reduces waking arousal and lowers thresholds for
transitions between wake and sleep, as occurs in narcolepsy.
Simulations indeed reveal an increase in sleep-wake fragmentation
as orexin levels are reduced, as well as changes to a range of other
key sleep-wake statistics. Finally, we explain how dynamics
resembling sleep inertia are predicted by the model due to an
asymmetry between sleep-to-wake and wake-to-sleep transitions.
Dependence of Sleep-wake Dynamics on Net Drives to
the VLPO and MA
In this section, we explain how the model’s dynamics depend on
the net drives to the sleep-wake switch: Dv and Dm. In particular,
we identify combinations of Dv and Dm that produce: (i) a stable
wake state, (ii) a stable sleep state, and (iii) where wake and sleep
are simultaneously stable and noise-induced transitions between
the two states are possible. The analysis will facilitate an
understanding of the full model dynamics, which will be
investigated in later sections. Note that the results of this section
hold equally for the current model and the original Phillips-
Robinson model [35], which was also centered around the
VLPO–MA sleep-wake switch, because the parameters that
determine the dynamical properties of this space: nvm and nmv,
and the sigmoidal function [Eq. (1)], are not altered in this work.
A reduced representation of the model, in terms of the net
drives Dv and Dm, is shown schematically in Fig. 1B. In Fig. 2A,
the model’s equilibrium states are labeled in this space and, as
might be expected intuitively, increasing Dv promotes sleep and
increasing Dm promotes wake. Importantly, we find an interme-
diate set of drives, Dv and Dm, for which sleep and wake states are
simultaneously stable (the bistable region shaded in Fig. 2A).
Model dynamics at fixed values of Dv and Dm are represented in
the space of the average cell-body potentials of the VLPO, Vv,
and the MA, Vm, as shown in the remaining Vv–Vm plots in
Figs. 2B–F, for selected values of Dv and Dm. The Vv–Vm plot was
introduced in previous work to analyze the model on timescales
shorter than that of changes in Dv and Dm, which can be treated
as control parameters of the fast dynamics [39].
Table 1. Nominal model parameter values.
Param. Value Param. Value Param. Value
Connection strengths nvm {2:1 mV s nmv {1:8 mV s nmx 0.3 mV s
vxv {1.0 mV s
Time constants tm 10 s tv 10 s tx 120 s
Sigmoid parameters Qmax 100 s{1 h 10 mV s
0 3m V
Drive parameters vvc {0.30 mV s vxc 1.0 mV s nvh 1:0 mV
Av {8.5 mV Am 0.52 mV Ax 1.0 mV
Homeostatic dynamics x 45 h h 17 s h 2.3
Noise standard deviation 1m V
Parameters either introduced or modified in this work are shown in boldface. All other parameter values correspond to those of the original Phillips-Robinson model,
which were constrained and subsequently verified on a broad range of experimental protocols including sleep deprivation [37,38], sleep fragmentation [39], caffeine
intake [40], mammalian sleep [41], shift work [42], and internal desynchrony [43] in previous work. New parameters introduced here are nmx, nxv, tx, nxc, Ax, and s.
doi:10.1371/journal.pone.0091982.t001
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nvc~{0:30 mV s (cf. File S1). In future work, physiological and
behavioral data could be used to further constrain the relative
contributions of these two circadian pathways (changes in whichThe system is awake at high Dm and low Dv: the region labeled
‘wake’ in Fig. 2A. In this region, the system attracts onto a single
stable equilibrium that corresponds to a waking state with high Vm
and low Vv (i.e., active MA and suppressed VLPO). The drives, Dv
and Dm, control the level of waking arousal in this region: Vm (and
hence Qm) increases with Dm (higher drive to wake) and decreases
with Dv (higher drive to sleep), and vice-versa for Qv. An example
Vv–Vm representation of the model in this waking region, at
(Dv,Dm)~(1:0,1:2) mV, is shown in Fig. 2B. Example time series
for Qv and Qm at these net drives with noise, plotted in the upper
panel of Fig. 2B, are the result of noisy deviations from the stable
waking state, combined with the attraction of the system back
toward equilibrium.
At high Dv and low Dm, the region labeled ‘sleep’ in Fig. 2A, the
system attracts onto a single stable equilibrium, as above, but now
the equilibrium is a sleep state with active VLPO and suppressed
MA. As before, the steady-state firing rate, Qv, of the sleep
equilibrium increases with Dv and decreases with Dm, and vice-
versa for Qm. An example is given for (Dv,Dm)~(1:6,0:6) mV in
Fig. 2C. Dynamics consist of noisy perturbations about the stable
sleep state.
More complex dynamics occur at intermediate Dv and Dm: the
shaded bistable region in Fig. 2A. The boundaries of this bistable
region correspond to saddle-node bifurcations of the model [39]
(see File S1 for mathematical details). We refer to the leftmost
boundary in Fig. 2A as the ‘wake bifurcation boundary’ (beyond
which only wake is stable), and the rightmost boundary as the
‘sleep bifurcation boundary’ (beyond which only sleep is stable). In
the bistable region, the stable wake and sleep equilibriums coexist,
and are separated by a separatrix in Vv–Vm space, which is plotted
as a dotted line in Figs. 2D–F. The two regions on either side of
this separatrix correspond to wake and sleep basins: when the
system is in the wake basin it will attract (deterministically) onto
the stable wake equilibrium and when it is in the sleep basin it will
attract (deterministically) onto the stable sleep equilibrium.
Transient external drives can cause the system to cross this
separatrix and thereby change state. We consider only the noise
processes jv(t) and jm(t) in this work, but note that other types of
impulsive drives could also cause a lasting change in the state of
the system, e.g., the short acoustic stimuli during sleep modeled in
previous work [39]. Three points in the bistable region, labeled D,
E, and F in Fig. 2A are shown in Figs. 2D–F and will be studied in
turn.
In the bistable region with Dm and Dv both high, e.g., for
(Dv,Dm)~(1:6,1:1) mV, shown in Fig. 2D, the sleep and wake
equilibriums are well-separated and the thresholds for transition-
ing between sleep and wake are high. Consequently, state
transitions are highly improbable, and the system mostly acts as
if only a single stable equilibrium exists: remaining either awake or
asleep depending on its initial condition. Time series are shown in
Fig. 2D for when the system is initially in a wake state, and when
the system is initially in a sleep state. In both cases, noise with s~1
mV is insufficient to change the state of the system (on timescales
meaningful to the current dynamics).
In the bistable region at lower net drives, Dv and Dm, the
thresholds for state transitions decrease so that noise can change
the state of the system. The probabilities of wake-to-sleep and
sleep-to-wake transitions depend on the position in the bistable
region, and are in general unequal. As the system approaches the
sleep bifurcation boundary, the wake equilibrium moves closer to
the saddle point and the sleep equilibrium moves further from the
saddle point, thereby biasing the transition probabilities further
toward sleep. The reverse occurs near the wake bifurcation
boundary, where sleep-to-wake transitions become increasingly
more probable than wake-to-sleep transitions. For example,
consider the point (Dv,Dm)~(1:11,0:61) mV, labeled ‘E’ in
Fig. 2A, which is nearer the sleep bifurcation boundary than the
wake bifurcation boundary. Here, thresholds for state transitions
are relatively low and the position of the wake equilibrium is closer
to the saddle point than the position of the sleep equilibrium, as
shown in Fig. 2E. Wake-to-sleep transitions are more probable
than sleep-to-wake transitions, and simulated time series, such as
that plotted in Fig. 2E, show the system mostly in sustained sleep
periods, while wake bouts are relatively short-lived.
Finally, we study the model dynamics at very low drives, Dv and
Dm, in the bistable region, using the point (Dv,Dm)~(1:05,0:58)
mV as an example, shown in Fig. 2F. In this region, the stable
sleep and wake equilibriums are both close to the saddle point so
that thresholds for state transitions are very low and hence state
transitions are highly probable with noise in the model. An
example time series generated at these net drives, shown in the
upper panel of Fig. 2F, is highly fragmented, with frequent
transitions between sleep and wake. Equilibrium mean firing rates
are relatively low: both Qv during sleep, Qv~2:9 s{1, and Qm
during wake, Qm~2:5 s{1, indicative of a weakening of the
normally pronounced sleep-wake distinction.
In summary, we have shown that lasting transitions between
sleep and wake can only occur for a subset of drives, Dv and Dm,i n
the bistable region, with state transition thresholds that decrease as
Dv and Dm decrease. Note that at low Dv and Dm beyond the
bistable region (i.e., the lower lefthand corner of Fig. 2A), mean
firing rates of both populations are low; this pathological regime is
not accessible for the parameters used in the current model
formulation (without adding persistent external drives).
The Effect of Orx on Thresholds for State Transitions
In this section, the above characterization of the model’s
dynamics as a function of Dv and Dm is used to understand how
time-varying inputs to both populations control the evolution of
arousal-state dynamics. As explained in Models above, the net drive
to VLPO, Dv [Eq. (7)], includes an oscillatory circadian input, C,a
homeostatic sleep drive, H, that increases during wake and
decreases during sleep, and other constant drives, Av. The net
drive to MA, Dm [Eq. (8)], includes an excitatory input from Orx,
nmxQx, and time-averaged drives from processes not modeled
here, Am. Each of these physiological mechanisms contributes to
moving the system through the Dv–Dm plane and their
combination determines the arousal-state dynamics of the model.
The model is examined without added noise in this section to
provide a preliminary understanding of the regions of the Dv–Dm
plane that the system moves through; the role of noise in
producing state transitions is investigated later.
For reference, we first describe the original Phillips-Robinson
model [35], in which Dm is constant and trajectories in the Dv–Dm
plane are horizontal lines. The combination of H and C provides
a net oscillatory drive, Dv, producing normal, flip-flop sleep-wake
dynamics, as shown in Fig. 3A. Due to the 24 h oscillation in Dv,
the system is driven back and forth between sleep and wake, falling
asleep at the sleep bifurcation boundary at high Dv and waking up
at the wake bifurcation boundary at a lower Dv. Because Dm is
constant, the Phillips-Robinson model can be represented as a
function of the single control parameter Dv (on timescales shorter
than that of changes in Dv [39]), yielding a hysteresis loop [35,38].
With Orx included, the new model produces a loop-like
trajectory through the Dv–Dm plane, shown in Fig. 3A. When the
system is asleep (plotted gray in Fig. 3A), Orx is inactive (i.e.,
Qx&0), due to inhibition from the VLPO, and Dv decreases,
mostly due to a decreasing homeostatic sleep drive, H. When the
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increase in Dm that moves the system out of the bistable region
where transitions between wake and sleep can occur. During the
waking period (plotted black in Fig. 3A), H builds, increasing Dv,
and the excitatory circadian input to Orx modulates waking
arousal levels, increasing Dm (and hence Qm) to a maximum at the
circadian peak. The system then moves rapidly through the
bistable region during the evening, with increasing H and
decreasing C moving the trajectory downwards and to the right,
eventually to a sufficiently low Dm that a transition back to sleep
occurs. After the system has fallen asleep, VLPO activates and
suppresses Orx, reducing Dm and preventing transitions back to
wake, thus facilitating another consolidated sleep bout. That Orx
activates during wake and is suppressed during sleep therefore
moves the system away from the bistable region where transitions
Figure 2. Model dynamics represented in terms of the net drives to the sleep-active VLPO, Dv, and the wake-active MA, Dm.AThree
distinct regions of Dv–Dm space are: (i) wake: at low Dv and high Dm a stable wake state exists, (ii) sleep: at high Dv and low Dm a stable sleep state
exists, and (iii) bistable (shaded): at intermediate Dv and Dm wake and sleep states are simultaneously stable and transient noise can produce lasting
changes of state. Simulated 5-h time series and Vv–Vm plots for fixed points in this space are shown in the remaining figures. Time series are plotted
for average firing rates of the VLPO, Qv (red), and the MA, Qm (blue). In the Vv–Vm plots, we include Vm nullclines (solid lines), Vv nullclines (dashed
lines), stable equilibriums (solid circles), saddle points (open circles), and the separatrix (dotted black line); see File S1 for definitions and numerical
details. B Dm is high and Dv is low; a single stable wake state exists. C Dv is high and Dm is low; a single stable sleep state exists. D In the bistable
region at high Dv and Dm, thresholds for transitions between wake and sleep are high and hence state transitions are extremely improbable: the
system remains either awake or asleep depending on its initial state (on timescales relevant to the current dynamics). E In the bistable region nearer
the sleep bifurcation boundary, transitions from wake to sleep are more probable than transitions from sleep to wake. F In the bistable region at low
Dv and Dm, thresholds for transitions between sleep and wake are low and simulated time series are highly fragmented.
doi:10.1371/journal.pone.0091982.g002
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wake.
Note that external influences, such as intense physical activity or
caffeine at the end of the day would contribute an arousing drive
and increase Dm (perhaps directly [80], and/or via Orx [81]), and
thereby prolong wake. Conversely, lying in bed in a dark room
would reduce the net input to the MA from arousing sensory
stimuli and decrease Dm, hastening the transition to sleep. These
examples help to demonstrate how the model could be applied to
intuitive real-world scenarios with more complicated environmen-
tal stimuli, but we do not pursue them further here.
Because Orx enters our model as an excitatory input to MA, we
can investigate model dynamics with Orx completely removed
from the model by setting nmx~0. This yields the small trajectory
labeled ‘no Orx’ in Fig. 3A. The trajectory occurs at a constant Dm
(~Am), and oscillates horizontally according to the homeostatic
and circadian components of Dv [Eq. (7)]. As explained above,
thresholds for state transitions in the bistable region at low Dv and
Figure 3. Noise-free model simulations represented as trajectories in terms of net drives to the VLPO, Dv, and MA, Dm, and as time
series. A The bistable region is shaded blue, and the wake and sleep regions are labeled. The trajectory for normal dynamics (i.e., including Orx)
forms a loop and is plotted using black (wake) and gray (sleep). The trajectory for the model without Orx is a small oscillation at low Dv and Dm, and is
labeled ‘no Orx’. The trajectory for the original Phillips-Robinson model occurs at fixed Dm~1:3 mV and is shown semi-transparent for comparison
(note that the wake trajectory of the Phillips-Robinson model extends beyond the limits of the figure to Dv&{2 mV). When Orx is removed from the
model, the system oscillates at low Dv and Dm, where thresholds for transitions between wake and sleep are low. However, with Orx in the model,
the wake and sleep states are stabilized: Orx is active during wake, increasing Dm, and Orx is suppressed during sleep, decreasing Dm, thereby
moving the system away from the bistable region where state transitions can occur and promoting consolidated wake and sleep episodes. Circadian
input to Orx modulates waking arousal levels: Dm is lower in the early morning and increases to a maximum at the circadian maximum, then
decreases through the afternoon and evening. Two-day time series for noise-free model dynamics (including Orx) are also plotted as: B Firing rates
Qv (black), Qm (blue), and Qx (green, dashed), C Net drives to the VLPO, Dv [black, Eq. (7)], and the MA, Dm [gray, Eq. (8)], and D Drives C [black, Eq.
(5)] and H [gray, Eq. (6)]. Approximate clock times for a typical sleep-wake schedule are given as a guide, and sleep periods are shaded.
doi:10.1371/journal.pone.0091982.g003
Figure 4. Removing Orx from the model produces fragmented sleep-wake time series characteristic of the narcoleptic phenotype.
Simulated 24-h time series are plotted for A Normal dynamics including Orx (i.e., nmx~0:3 mV s) for Qm (blue), Qv (green), and Qx (orange), and B
Fragmented dynamics with Orx removed from the model (i.e., nmx~0). Periods of sleep, with QvwQm (black), and wake, with QmwQv (white), are
shown in the strip above the main plot. When nmx is reduced, the system moves from a regime in which Orx stabilizes extended wake and sleep
bouts, to a regime characterized by low waking arousal levels and increased fragmentation due to a lowering of the threshold for state transitions.
doi:10.1371/journal.pone.0091982.g004
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during sleep (cf. Fig. 2F). This region of the drive space, which
results from eliminating Orx from our model, thus characterizes
many of the known properties of the narcoleptic phenotype: low
thresholds for transitions between states and low waking arousal.
In simulations below, we will show that when noise is added to the
model, the dynamics of sleep and wake are correspondingly
fragmented.
Thus, the model predicts three key mechanisms through which
Orx acts to stabilize prolonged sleep and wake episodes: (i) Orx
excites the MA during wake, increasing Dm, enhancing waking
arousal levels, Qm, and raising the threshold for transitions to sleep
during a wake episode, (ii) Orx is suppressed by the VLPO during
sleep, decreasing Dm and preventing transitions back to wake, and
(iii) The excitatory circadian drive to Orx is relayed to the MA
during wake, further stabilizing wake during waking circadian
phases. Orx therefore stabilizes both wake (by increasing Dm during
wake) and sleep (by decreasing Dm during sleep).
Two-day time series for Qv, Qm, and Qx, generated by the
noise-free model (including Orx) are plotted in Fig. 3B. During
sleep, Qv is high and decreases across the night until the transition
to wake, during which Orx relays a circadian variation in waking
arousal levels, which peaks with the circadian drive near the
middle of the wake episode (cf. Fig. 3D). As shown in Fig. 3C, Dv is
dominated by H, which decreases during sleep and increases
during wake. The net drive to MA, Dm, is low during sleep and
high during wake, reflecting Orx activity. Notice that the circadian
input to Orx has a negligible effect on the system during sleep
when Orx is suppressed, but plays an important role in modulating
Orx (and hence MA) activity during wake. Time series for H and
C are plotted in Fig. 3D for comparison.
Simulating Narcolepsy
In this section, we include noise in the model and use
simulations to explain how the loss of Orx leads to the behavioral
state instability that characterizes narcolepsy. As described above,
because Orx enters our model as an excitatory input to MA, Orx
loss can be simulated by reducing nmx. Note that here we simulate
a total loss of Orx by setting nmx~0, as an Orx knockout or severe
narcoleptic, rather than the approximately 90% reduction that
occurs in narcolepsy (i.e., to nmx~0:03 mV s) to simplify the
analysis; the difference is small and a detailed investigation into the
dependence of the dynamics on nmx is provided below. Simulated
24 h firing rate time series are plotted for normal sleep-wake
Figure 5. Model dynamics as a function of orexin levels, corresponding to the model parameter mx.APeriods of sleep(black)andwake
(white) are plotted as a function of nmx across two-day model simulations. B The circadian drive, C, versus time. Various statistics taken from the
model output are plotted as a function of nmx as the mean (solid) + standard deviation (dotted) measured across a 25 day model simulation
(following a 3 day equilibration period), for C Total sleep duration per day, D Number of state transitions per day, E Duration of sleep bouts, F Qm
during wake (blue) and Qv during sleep (black), and G Homeostatic sleep drive, H.
doi:10.1371/journal.pone.0091982.g005
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behavior, with nmx~0:3 mV s, in Fig. 4A, and with nmx~0 in
Fig. 4B. No other parameters were altered between these
simulations.
The model’s outputs for normal sleep-wake behavior (in Fig. 4)
resemble those shown above for the noise-free case, with Orx
stabilizing extended daily wake and sleep episodes. With noise in
the model, sleep becomes viable toward the end of the evening (cf.
Fig. 3A), where the threshold for a transition to sleep decreases,
allowing external influences (noise in this simulation), to determine
the precise timing of the wake-to-sleep transition. The model
produces realistic firing rates, both in terms of their magnitudes
and temporal organization, for all populations. For example,
physiological data suggest that Qx is approximately 4–8 s{1
during wake and v1 s{1 during sleep [81,82]; the model has
Qx&4–7 s{1 during wake and Qxv1 s{1 during sleep, while
firing rates for MA and VLPO are similar to those produced by
the original Phillips-Robinson model.
Simulated 24 h firing rate time series with Orx absent from the
model (i.e., nmx~0) are plotted in Fig. 4B. As explained above,
thresholds for state transitions at low Dv and Dm in the bistable
region are very low, with noise causing frequent state transitions.
Without Orx to increase Dm and stabilize wake, or decrease Dm to
stabilize sleep, the system no longer has a mechanism for
producing extended episodes of either wake or sleep. When the
system is asleep, H decreases, pushing the system to lower Dv
where transitions to wake are more probable. Conversely, when
the system is awake, H increases and pushes the system to higher
Dv, where transitions to sleep are more probable. The system is
unable to escape this cycle of severe sleep-wake fragmentation.
Circadian input to the VLPO adds a circadian phase dependence
to the probability of the system being awake (higher at higher C)
or asleep (higher at lower C). Waking arousal levels (Qm) are
reduced compared to normal individuals because Orx increases
Dm during wake, a mechanism that is absent without Orx. Two
main consequences of decreasing nmx in our model are therefore
lower waking Qm, and lower thresholds for state transitions,
corresponding to two key features of the narcoleptic phenotype.
Figure 6. Dependence of sleep-to-wake and wake-to-sleep transitions on the timescale for Orx dynamics, x. Time series for the firing
rates of MA, Qm (blue), VLPO, Qv (black), and Orx, Qx (green), are plotted for the sleep-to-wake (A–C) and wake-to-sleep (D–F) transitions for tx~10 s
(A, B), tx~5 min (B, E), and tx~15 min (C, F), as a function of time relative to the change of state. The plots were produced by averaging 50 model
runs relative to the time of the state transition; one standard deviation about the mean is shown dotted. The approximate steady state firing rate for
Qm is annotated as a dashed purple line in A–C, and for Qv in D–F. The parameter tx selectively tunes the duration of the sleep-to-wake transition
but has minimal effect on the wake-to-sleep transition. This gradual wake transition can be linked to the clinical phenomenon of sleep inertia.
doi:10.1371/journal.pone.0091982.g006
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t t t tDependence of Sleep-wake Dynamics on Orexin Levels
In this section, we explore how simulated sleep-wake dynamics
depend on nmx across the full range 0ƒnmxƒ0:3 mV s. Results
are shown in Fig. 5. In Fig. 5A, the gradual increase in sleep-wake
fragmentation that results from decreasing nmx in our model is
shown for two-day simulations by plotting sleep (black) and wake
(white) periods. Prior to each simulation, the model was
equilibrated by simulating it for three days at each given nmx.A s
nmx decreases down to a reduction of approximately 50% (i.e.,
nmx&0:15 mV s), consolidated bouts of sleep and wake are still
possible, but with sleep periods commencing at an earlier
circadian phase (i.e., morningness). The model thus predicts that
consolidated sleep is robust to modest differences in orexin levels,
but also that these differences may contribute to differences in
chronotype. This represents an important potential addition to the
list of factors that are already known to influence chronotype:
inter-individual differences in patterns of self-selected light
exposure, and differences in circadian and homeostatic processes
[83]. This observation may also offer a potential explanation for
the tendency to morningness and more fragmented sleep with
aging [84], as orexin levels gradually decline [85]. The predicted
phase advance of sleep with reduction in orexin levels should be
investigated further–if borne out in clinical experiments, it may
also have therapeutic value for early disease detection, for
example.
At more severe levels of Orx loss (* >50% reduction), the system
can no longer sustain extended bouts of sleep and wake. Through
the mechanisms explained in the preceding sections, sleep-wake
fragmentation increases as nmx decreases: both naps during normal
wake periods, and awakenings during normal sleep periods.
Figure 5A reveals sharp wake-to-sleep transitions, but more
volatile sleep-to-wake transitions (often exhibiting ‘snoozing’ back
to sleep, for example); this asymmetry is related to the role of Orx
in sleep inertia, and is characterized in detail below. The two day
time series for the circadian drive, C(t), in Fig. 5B, reveals a strong
circadian phase dependence of sleep and wake across a wide range
of nmx.
The model predicts that decreasing orexin levels affects a range
of relevant sleep-wake statistics. A selection of summary statistics of
the model’s output across 25 day model simulations are shown in
Figs. 5C–G at each of 51 equally-spaced points for 0ƒnmxƒ0:3
mV s. Figure 5C shows that the total sleep time remains
approximately constant with changes in nmx, a feature that is
observed clinically [86] and was used to fit the model (see File S1).
As shown in Fig. 5D, the number of state transitions per day
remains at two (one sleep and one wake transition) when
nmx * > 0:15 mV s, then increases smoothly as nmx decreases, to
approximately 53 per day when nmx~0. The mean duration of
sleep bouts correspondingly decreases for nmx 0:15 mV s, as
plotted in Fig. 5E. The firing rates, Qm during wake, and Qv
during sleep, shown in Fig. 5F, decrease as nmx decreases, due to
reduced promotion of wake. As shown in Fig. 5G, the mean value
of H decreases slightly as nmx is decreased, from SHTt&10:5 for
nmx~0:3 mV s (normals) to SHTt&9:5 for nmx~0.
Note that only the single model parameter, nmx, was altered in
these simulations; the circadian and homeostatic drives were not
changed, consistent with available experimental evidence suggest-
ing that the circadian and homeostatic processes themselves
appear to be normal in narcoleptics [13,19]. We also emphasize
that our aim is to show the qualitative behavior of our model as
orexin levels decrease, while the quantitative values predicted
could be fitted to specific clinical datasets in the future.
Sleep Inertia
Having explained how Orx stabilizes sleep and wake, and
demonstrated that its loss produces sleep-wake fragmentation, in this
final section we investigate how Orx affects the dynamics of state
transitions. In our model, the timescale on which Orx dynamics
occur, tx, determines the timescale on which the MA receives an
excitatory input upon awakening, and also the timescale on which
this input is reduced following a transition to sleep. Here we show
that this timescale selectively affects the sleep-to-wake transition,
producing dynamics resembling sleep inertia, and discuss how the
mechanism has a more general role in stabilizing arousal state
changes, including naps during wake and awakenings during sleep.
The model predicts an asymmetry between the wake-to-sleep
and sleep-to-wake transitions. In the original Phillips-Robinson
model, the input to the MA was a constant, but in the current
model, the input varies with Orx activity, which increases from a
low value during a sleep-to-wake transition, and decreases from a
high value during a wake-to-sleep transition. This change has a
minimal effect on the wake-to-sleep transition, which occurs at high
Dv and Dm (cf. Fig. 3A), and is sharp, with the system attracting
rapidly onto the sleep equilibrium. Once the system has begun to
attract onto the sleep equilibrium, the threshold for a transition
back to wake is very high and thus highly unlikely. By contrast, the
sleep-to-wake transition is much more volatile because it occurs at
low Dv and Dm (cf. Fig. 3A) where the thresholds for state
transitions are low. In addition, the circadian drive, C, and hence
Orx activity are both low in the morning, yielding low waking
arousal levels, Qm, immediately following a normal morning
awakening. For normal dynamics, the model therefore produces
abrupt wake-to-sleep transitions but gradual and relatively volatile
sleep-to-wake transitions (with the possibility of snoozing back to
sleep). These qualitative dynamics resemble sleep inertia, a well-
knownphenomenon[87–90]thatdescribeshow‘‘immediatelyafter
awakening from sleep, alertness is low’’ [91].
We find that the timescale for the sleep-to-wake transition
depends on the timescale for Orx dynamics, tx. To demonstrate
this, we plot time series for Qm(t), Qv(t), and Qx(t) for normal
sleep-to-wake and wake-to-sleep transitions in Fig. 6 for selected
values of tx~10 s, tx~5 min, and tx~10 min. The time
constants tv and tm are maintained at their previous values of 10 s,
for consistency with previous work (including the model’s response
to external stimuli [39]). As shown in Figs. 6A–C, tx controls the
timescale on which Orx activates during sleep-to-wake transitions,
and hence that on which Qm, and waking arousal levels, increase
to a steady level. This gradual sleep-to-wake transition stems from
a longer timescale, tx, and constitutes a plausible mechanism for
sleep inertia. Time series for wake-to-sleep transitions for the same
three values of tx are plotted in Figs. 6D–F. Because normal wake-
to-sleep transitions occur when Dv and Dm are high, the system
attracts rapidly onto the sleep state, and the wake-to-sleep
transition exhibits minimal dependence on tx. The parameter tx
thus selectively tunes the timescale of sleep inertia in our model.
Depending on the study and the way sleep inertia is measured,
its duration has been found to range from a few minutes to several
hours, but in the absence of severe sleep deprivation, rarely
exceeds 30 min [89]. For all simulations in this work, we set tx~2
min, for which Qm saturates over approximately 6 min following a
normal morning awakening. The longer timescale for sleep inertia
reported in some clinical studies [87,88] may reflect the circadian
input to Orx, which increases arousal levels, Qm, following an
awakening on a longer timescale (to a maximum at the circadian
peak in the mid-afternoon for a normal sleep-wake schedule,
cf. Fig. 4A). Thus, while other models have used ad hoc processes
to reproduce the dynamics of sleep inertia (e.g., the exponentially-
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modeling known physiological interactions.
As well as having a role in state transition dynamics, Orx
controls the dynamics of all state transitions in the model,
including naps during normal wake periods and awakenings
during normal sleep periods. We first note that lasting changes of
state could only occur in the original Phillips-Robinson model for
the small range of drives, Dv, in the bistable region, due to a
transient external stimulus, for example. By contrast, the new
model is able to stabilize lasting changes of state when the system is
not in the bistable region due to Orx, which activates to stabilize
wake (increasing Dm), and deactivates to stabilize sleep (decreasing
Dm) on a timescale tx. Thus, although changes in state can be
produced by external drives acting on the relatively short timescale
of tv and tm, the system can remain in the new state after the
external stimulus is removed if it persists on a timescale that is
sufficientlylongtochangetheactivityof Orx(i.e.,longer than t tx).
Intuitively, this behavior could correspond to relative difficulty
returning to sleep after awakening in the night for more than a
brief duration( t tx),becausethisarousalpersistsforsufficientlylong
to activate Orx, stabilizing the wake state and preventing a rapid
return back to sleep. Incorporating an excitatory input from Orx
to MA in the model hence provides a more flexible framework for
modeling state changes, with the time constant tx constituting a
key timescale for both sleep inertia, and the stabilization of
prolonged naps during wake and awakenings during sleep.
Summary and Conclusion
In this work, a new model of sleep-wake physiology was developed
that includes Orx. Using established physiological knowledge, the
model addresses a key shortcoming in current understanding of
narcolepsy by providing a clear physiological explanation of how
arousal state instability stems from Orx loss. A physiologically
plausible set of parameters is able to reproduce previously reported
sleep-wake behavior, explain many features of the narcoleptic
phenotype,and make newpredictions.The main resultsare as follows:
(i) The new model produces realistic dynamics, including
firing rates, relevant drives, and the temporal organization
of sleep and wake periods.
(ii) Fragmented sleep-wake time series characteristic of the
narcoleptic phenotype are generated by simulating a
reduction in orexin levels, yielding reduced daytime
arousal with a constant daily total duration of sleep,
without altering any other parameters or drives.
(iii) The model predicts a shift of the sleep-wake schedule
toward a morning chronotype with reduction in orexin
levels, a prediction that may have relevance in under-
standing the increase in morningness and sleep-wake
fragmentation with aging.
(iv) While previous models have captured sleep inertia using ad
hoc processes, an asymmetry between sleep-to-wake and
wake-to-sleep transitions is predicted to result from adding
Orx to the model, producing sleep inertia on the timescale
of Orx dynamics, tx. This timescale is shown to affect all
state transitions, including naps during normal wake
periods and awakenings during normal sleep periods.
Existing physiologically based models of sleep-wake dynamics
have captured some elements of the role of Orx using alternative
approaches. Unlike other models, our approach builds from a
simplified model of the core physiology and does not attempt to
include everything. This approach has the advantage of being able
to model large networks of individual neurons as interacting
populations, and producing easily-interpretable dynamics that
reproduce many features of narcoleptic dynamics. In one model of
mouse sleep-wake behavior by Diniz Behn et al. [30], Orx was
modeled as a state-dependent modulation of the inhibition of the
VLPO by wake-active neuronal populations using a saturating
mathematical form that mimics Orx activation on a timescale of
minutes or longer. This form ensures that Orx does not affect brief
arousals, but only activates during extended wake periods (lasting
longer than 1min)[30,31].Orxplays aqualitativelysimilarrolein
our model, but the dynamics result from directly modeling its
interactions with other neuronal populations, including circadian
input, which were not included in their model [30,31]. Another
physiologically based sleep model was proposed by Rempe et al.
[33], that includes a similar set of neuronal populations and
interactions as modeled here, butalso includedREM-offand REM-
on populations, the eVLPO, and used a Morris-Lecar system to
modeleachpopulationasifitwereanindividual,representativecell.
Their model includes Orx as a drive to monoaminergic nuclei that
is, by construction, ‘switched on’ during wake (when it relays a
purely circadian variation), and ‘switched off’ during sleep, whereas
in our model Orx is included as a neuronal population with its own
dynamics, more closely representing this aspect of the known
physiology. The Rempe et al. [33] model successfully produced
additional cycles between arousal states when removing the
influence of Orx, but a relatively small number of features of the
narcoleptic phenotype were reproduced.
Future modeling work could attempt to capture and account for
the considerable inter-individual variation in narcoleptic symptoms
[15] by relating changes in sleep-wake dynamics to changes in
underlying model parameters (including nmx, Am,a n ds,w h i c ha l l
affect the rate of state transitions) using hypnograms recorded from
narcoleptic dogs [93], mice [94], and humans [22], for example.
Fitting the model to individual data may allow us to infer the degree
of Orx loss, for example, with potential to recommend pharmaco-
logicalorbehavioraltreatmentstoindividuals.Themodel’sincreased
flexibility to simulate state changes also makes it well placed to
investigate the statistics of wake and sleep bout durations, a subject
that has received much attention [95]. This model could include
pharmaceutical agents, as has been demonstrated for caffeine in the
original Phillips-Robinson model [40]. For example, orexin receptor
antagonists such as suvorexant [96] could be modeled straightfor-
wardly, or modafinil could be modeled as increasing norepine-
phrinergic inhibition of the VLPO [97]. The model introduced here
is thus flexible and well-placed to contribute to a unified
understanding of a wide range of sleep-wake phenomena in terms
of a simplified representation of the core underlying physiology.
Supporting Information
File S1 Additional modeling details. This supplementary
file contains additional mathematical detail of our the model, how
its parameters have been constrained, a brief application to sleep
deprivation, and a description of our heuristic for labeling ‘sleep’
and ‘wake’ periods.
(PDF)
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